FOMAT is looking forward to attending the 2026 ADA Scientific Sessions in New Orleans, taking place June 5 to 8, 2026. As a key event in the diabetes space, the conference offers a strong environment for exchanging ideas, following new developments, and connecting with others contributing to progress in research and care.
Attending on behalf of FOMAT will be Brandon Johnson, Manager of Business Development. His participation reflects our interest in building new relationships and continuing conversations that support the growth of clinical trials in diabetes. We would be pleased to connect during the meeting in New Orleans.
